External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study

•As the selection of the optimal cytoreductive nephrectomy candidate is challenging, we validate the utility of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) score, a novel risk stratification model, in patients with primary metastatic renal cell carcinoma who were treated with first-li...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urologic oncology 2021-12, Vol.39 (12), p.836.e11-836.e17
Hauptverfasser:	Okita, Kazutaka, Hatakeyama, Shingo, Naito, Sei, Numakura, Kazuyuki, Kato, Renpei, Koguchi, Tomoyuki, Kojima, Takahiro, Kawasaki, Yoshihide, Kandori, Shuya, Kawamura, Sadafumi, Nishiyama, Hiroyuki, Ito, Akihiro, Kojima, Yoshiyuki, Habuchi, Tomonori, Obara, Wataru, Tsuchiya, Norihiko, Ohyama, Chikara
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Carcinoma, Renal Cell - pathology Carcinoma, Renal Cell - surgery Cytoreduction Surgical Procedures - methods Cytoreductive nephrectomy Female Humans Kidney Neoplasms - pathology Kidney Neoplasms - surgery Male Metastatic renal cell carcinoma Middle Aged Neoplasm Metastasis Nephrectomy - methods Retrospective Studies Risk model Tyrosine kinase inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!